Philippa J. Cheetham, MD | Authors

New Agents for the Treatment of Advanced Bladder Cancer

June 15, 2016

This article will review select novel targets and approaches relevant to urothelial cancer.

Alpha Particles as Radiopharmaceuticals in the Treatment of Bone Metastases: Mechanism of Action of Radium-223 Chloride (Alpharadin) and Radiation

April 15, 2012

This article will present current information about alpha-pharmaceuticals, a new class of targeted cancer therapy for the treatment of patients with CRPC and bone metastases. It will review preclinical and clinical studies of the experimental radiopharmaceutical radium-223 chloride (Alpharadin).